Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SGHT · against 465 other Healthcare companies of similar size
Ranked #301 of 466 · scores higher than 12% of peers
Bars: peers in each 10-point band of the valuation score166 peers with a valuation score of 0–9, including SGHT · Click a bar to see the companies
Mainly because of its EBITDA yield, earnings yield and free cash flow yield, which are weaker than most Healthcare peers.
| Metric | SGHT | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 453 reported | -5.8% | 0.5% | 32% | 30% | |
| EBITDA yieldHigher is better · 471 reported | -4.0% | 3.5% | 26% | 50% | |
| Free cash flow yieldHigher is better · 202 reported | -4.5% | -6.7% | 55% | 20% | |
| Book yieldHigher is better · 462 reported | 10.3% | 48.0% | 10% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 1 | 6.50T IDR (≈$403M) | 99 | 69 | |
| 301 | 504M USD | 8 | 24 | |
| 301 | 388M USD | 8 | 36 | |
| 301 | 730M USD | 8 | 11 | |
| 301 | 468M USD | 8 | 40 | |
| 301 | 519M USD | 8 | 22 | |
| 301 | 673M USD | 8 | 35 | |
| 301 | 588M USD | 8 | 24 | |
| 301 | 303M USD | 8 | 27 | |
| 301 | 354M USD | 8 | 13 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score